Clear Street’s Sunshine Biopharma Inc Warrant SBFMW Stock Holding History

Clear Street’s Portfolio SBFMW Stock Details SBFMW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-94	Closed	-$14	–	994
2025 Q3	$14	Hold	94	–	–	﹤0.01%	832
2025 Q2	$27	Hold	94	–	–	﹤0.01%	658
2025 Q1	$19	Buy	+94	New	+$21	﹤0.01%	555
2024 Q3	–	Sell	-1,876	Closed	-$131	–	750
2024 Q2	$131	Hold	1,876	–	–	﹤0.01%	733
2024 Q1	$91	Sell	1,876 -200	-10%	-$21	﹤0.01%	738
2023 Q4	$415	Sell	2,076 -100	-5%	-$22	﹤0.01%	703
2023 Q3	$489	Sell	2,176 -200	-8%	-$62	﹤0.01%	950
2023 Q2	$898	Buy	2,376 +400	+20%	+$180	﹤0.01%	1081
2023 Q1	$988	Buy	+1,976	New	+$1.03K	﹤0.01%	972
2022 Q2	–	Sell	-14,126	Closed	-$14K	–	1043
2022 Q1	$14K	Buy	+14,126	New	+$9.86K	﹤0.01%	236

Other funds holding SBFMW

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Clear Street's SBFMW Position: Q4 2025 in Review

Clear Street sold out of Sunshine Biopharma Inc Warrant (SBFMW) in Q4 2025, closing a stake of 94 shares — an estimated $14 sold.

Clear Street first reported a position in SBFMW in Q1 2022 and held it in 10 quarters. The position peaked at $14K in Q1 2022. 1 fund tracked by Wall St. Rank holds SBFMW as of Q4 2025.

Clear Street reported no remaining Sunshine Biopharma Inc Warrant position as of Q4 2025 after selling out during the quarter.
Clear Street sold 94 Sunshine Biopharma Inc Warrant shares in Q4 2025, an estimated $14.
Clear Street first reported a position in Sunshine Biopharma Inc Warrant in Q1 2022 and held it in 10 quarters.
Clear Street's Sunshine Biopharma Inc Warrant position peaked at $14K in Q1 2022.
1 fund tracked by Wall St. Rank held Sunshine Biopharma Inc Warrant as of Q4 2025.

Based on Clear Street's 13F filing for Q4 2025, filed 13 Feb 2026.